Loading...
Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors
Hot flashes in breast cancer survivors (BCS) receiving adjuvant aromatase inhibitor (AI) therapy are common, but risk factors for these symptoms are ill-defined. This study tested if body size is associated with hot flashes in BCS on AI therapy. A cross-sectional study of postmenopausal BCS receivin...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3670946/ https://ncbi.nlm.nih.gov/pubmed/20182796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-010-0802-6 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|